US Stock MarketDetailed Quotes

ACST Acasti Pharma

Watchlist
  • 3.0600
  • -0.1300-4.08%
Close Jun 7 16:00 ET
  • 3.0000
  • -0.0600-1.96%
Post 17:55 ET
28.76MMarket Cap-613P/E (TTM)

Acasti Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.32%3.04M
-59.04%2.09M
-37.23%2.97M
18.95%18.25M
-5.41%4.17M
0.47%4.25M
43.20%5.11M
50.40%4.73M
41.57%15.34M
124.41%4.4M
Selling and administrative expenses
-9.86%1.6M
-10.78%1.63M
-10.65%1.87M
-16.04%8.21M
21.14%2.52M
-13.25%1.78M
-38.70%1.83M
-21.75%2.09M
46.97%9.78M
37.64%2.08M
-Selling and marketing expense
-58.33%30K
1,333.33%43K
500.00%60K
17.24%136K
34.21%51K
-7.69%72K
--3K
--10K
-89.84%116K
-42.42%38K
-General and administrative expense
-7.81%1.57M
-12.99%1.59M
-13.10%1.81M
-16.44%8.08M
20.89%2.47M
-13.47%1.7M
-38.80%1.83M
-22.12%2.08M
75.31%9.67M
41.30%2.04M
Research and development costs
-41.10%1.44M
-86.03%460K
-57.72%1.1M
79.38%9.97M
-29.49%1.64M
12.44%2.45M
462.74%3.29M
452.24%2.59M
33.21%5.56M
69.91%2.33M
Depreciation amortization depletion
----
108.33%1K
-93.48%3K
--63K
--9K
--20K
---12K
--46K
--0
--0
-Depreciation and amortization
----
108.33%1K
-93.48%3K
--63K
--9K
--20K
---12K
--46K
--0
--0
Operating profit
28.32%-3.04M
59.04%-2.09M
37.23%-2.97M
-18.95%-18.25M
5.41%-4.17M
-0.47%-4.25M
-43.20%-5.11M
-50.40%-4.73M
-43.15%-15.34M
-133.33%-4.4M
Net non-operating interest income expense
371.64%316K
488.89%212K
318.75%134K
219.48%246K
198.25%112K
67.50%67K
157.14%36K
-76.98%32K
149.04%77K
51.28%-114K
Non-operating interest income
371.64%316K
488.89%212K
318.75%134K
219.48%246K
198.25%112K
67.50%67K
157.14%36K
60.00%32K
-28.04%77K
-480.00%-114K
Other net income (expense)
753.33%128K
-15,225.00%-1.84M
-2,072.06%-1.48M
-808.30%-33.97M
-96,771.43%-33.91M
-96.31%15K
-100.26%-12K
39.29%-68K
154.47%4.8M
99.01%-35K
Gain on sale of security
753.33%128K
-15,225.00%-1.84M
111.76%8K
-101.27%-62K
101.65%3K
-97.71%15K
-100.26%-12K
39.29%-68K
257.90%4.9M
94.61%-182K
Special income (charges)
--0
--0
---1.49M
-13,517.67%-33.91M
---33.91M
--0
--0
--0
95.63%-249K
--0
-Less:Restructuring and merger&acquisition
--0
--0
--1.49M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
----
----
----
--33.51M
----
----
----
----
--0
----
-Write off
----
----
----
60.64%400K
----
----
----
----
-39.71%249K
--0
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
--147K
----
Income before tax
37.57%-2.6M
26.85%-3.72M
9.53%-4.31M
-396.52%-51.97M
-733.88%-37.96M
-10.19%-4.16M
-618.25%-5.08M
-52.85%-4.77M
46.81%-10.47M
19.38%-4.55M
Income tax
24.09%-208K
-187.74%-446K
-19.42%-289K
-1,372.53%-9.54M
-1,268.98%-8.87M
-274K
-155K
-242K
-648K
-648K
Net income
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
50.10%-9.82M
30.85%-3.9M
Net income continuous Operations
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
50.10%-9.82M
30.85%-3.9M
Minority interest income
Net income attributable to the parent company
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
50.10%-9.82M
30.85%-3.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
-2.94%-3.89M
-602.45%-4.93M
-45.09%-4.52M
50.10%-9.82M
30.85%-3.9M
Basic earnings per share
37.50%-0.0542
34.85%-0.0717
11.48%-0.54
-251.85%-5.7
-639.63%-3.9119
83.95%-0.0867
-161.11%-0.11
15.28%-0.61
79.70%-1.62
59.33%-0.5289
Diluted earnings per share
37.50%-0.0542
34.85%-0.0717
11.48%-0.54
-251.85%-5.7
-639.63%-3.9119
83.95%-0.0867
-161.11%-0.11
15.28%-0.61
79.70%-1.62
59.33%-0.5289
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.32%3.04M-59.04%2.09M-37.23%2.97M18.95%18.25M-5.41%4.17M0.47%4.25M43.20%5.11M50.40%4.73M41.57%15.34M124.41%4.4M
Selling and administrative expenses -9.86%1.6M-10.78%1.63M-10.65%1.87M-16.04%8.21M21.14%2.52M-13.25%1.78M-38.70%1.83M-21.75%2.09M46.97%9.78M37.64%2.08M
-Selling and marketing expense -58.33%30K1,333.33%43K500.00%60K17.24%136K34.21%51K-7.69%72K--3K--10K-89.84%116K-42.42%38K
-General and administrative expense -7.81%1.57M-12.99%1.59M-13.10%1.81M-16.44%8.08M20.89%2.47M-13.47%1.7M-38.80%1.83M-22.12%2.08M75.31%9.67M41.30%2.04M
Research and development costs -41.10%1.44M-86.03%460K-57.72%1.1M79.38%9.97M-29.49%1.64M12.44%2.45M462.74%3.29M452.24%2.59M33.21%5.56M69.91%2.33M
Depreciation amortization depletion ----108.33%1K-93.48%3K--63K--9K--20K---12K--46K--0--0
-Depreciation and amortization ----108.33%1K-93.48%3K--63K--9K--20K---12K--46K--0--0
Operating profit 28.32%-3.04M59.04%-2.09M37.23%-2.97M-18.95%-18.25M5.41%-4.17M-0.47%-4.25M-43.20%-5.11M-50.40%-4.73M-43.15%-15.34M-133.33%-4.4M
Net non-operating interest income expense 371.64%316K488.89%212K318.75%134K219.48%246K198.25%112K67.50%67K157.14%36K-76.98%32K149.04%77K51.28%-114K
Non-operating interest income 371.64%316K488.89%212K318.75%134K219.48%246K198.25%112K67.50%67K157.14%36K60.00%32K-28.04%77K-480.00%-114K
Other net income (expense) 753.33%128K-15,225.00%-1.84M-2,072.06%-1.48M-808.30%-33.97M-96,771.43%-33.91M-96.31%15K-100.26%-12K39.29%-68K154.47%4.8M99.01%-35K
Gain on sale of security 753.33%128K-15,225.00%-1.84M111.76%8K-101.27%-62K101.65%3K-97.71%15K-100.26%-12K39.29%-68K257.90%4.9M94.61%-182K
Special income (charges) --0--0---1.49M-13,517.67%-33.91M---33.91M--0--0--095.63%-249K--0
-Less:Restructuring and merger&acquisition --0--0--1.49M----------0--0--0--------
-Less:Impairment of capital assets --------------33.51M------------------0----
-Write off ------------60.64%400K-----------------39.71%249K--0
Other non- operating income (expenses) ----------------------------------147K----
Income before tax 37.57%-2.6M26.85%-3.72M9.53%-4.31M-396.52%-51.97M-733.88%-37.96M-10.19%-4.16M-618.25%-5.08M-52.85%-4.77M46.81%-10.47M19.38%-4.55M
Income tax 24.09%-208K-187.74%-446K-19.42%-289K-1,372.53%-9.54M-1,268.98%-8.87M-274K-155K-242K-648K-648K
Net income 38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M-2.94%-3.89M-602.45%-4.93M-45.09%-4.52M50.10%-9.82M30.85%-3.9M
Net income continuous Operations 38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M-2.94%-3.89M-602.45%-4.93M-45.09%-4.52M50.10%-9.82M30.85%-3.9M
Minority interest income
Net income attributable to the parent company 38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M-2.94%-3.89M-602.45%-4.93M-45.09%-4.52M50.10%-9.82M30.85%-3.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M-2.94%-3.89M-602.45%-4.93M-45.09%-4.52M50.10%-9.82M30.85%-3.9M
Basic earnings per share 37.50%-0.054234.85%-0.071711.48%-0.54-251.85%-5.7-639.63%-3.911983.95%-0.0867-161.11%-0.1115.28%-0.6179.70%-1.6259.33%-0.5289
Diluted earnings per share 37.50%-0.054234.85%-0.071711.48%-0.54-251.85%-5.7-639.63%-3.911983.95%-0.0867-161.11%-0.1115.28%-0.6179.70%-1.6259.33%-0.5289
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg